OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cellular-Based Therapies in Systemic Sclerosis: From Hematopoietic Stem Cell Transplant to Innovative Approaches
Elisabetta Xue, Antonina Minniti, Tobias Alexander, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3346-3346
Open Access | Times Cited: 11
Elisabetta Xue, Antonina Minniti, Tobias Alexander, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3346-3346
Open Access | Times Cited: 11
Showing 11 citing articles:
Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee
Raffaella Greco, Tobias Alexander, Nicoletta Del Papa, et al.
EClinicalMedicine (2024) Vol. 69, pp. 102476-102476
Open Access | Times Cited: 31
Raffaella Greco, Tobias Alexander, Nicoletta Del Papa, et al.
EClinicalMedicine (2024) Vol. 69, pp. 102476-102476
Open Access | Times Cited: 31
Human Regulatory T Cells: Understanding the Role of Tregs in Select Autoimmune Skin Diseases and Post-Transplant Nonmelanoma Skin Cancers
Nicole Chizara Oparaugo, Kelsey Ouyang, Nam Phuong N. Nguyen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1527-1527
Open Access | Times Cited: 28
Nicole Chizara Oparaugo, Kelsey Ouyang, Nam Phuong N. Nguyen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1527-1527
Open Access | Times Cited: 28
Novel therapeutic strategies for autoimmune and inflammatory rheumatic diseases
Renaud Felten, Philippe Mertz, E. Sebbag, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 7, pp. 103612-103612
Open Access | Times Cited: 14
Renaud Felten, Philippe Mertz, E. Sebbag, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 7, pp. 103612-103612
Open Access | Times Cited: 14
An international perspective on the future of systemic sclerosis research
David Abraham, Carol M. Black, Christopher P. Denton, et al.
Nature Reviews Rheumatology (2025)
Closed Access
David Abraham, Carol M. Black, Christopher P. Denton, et al.
Nature Reviews Rheumatology (2025)
Closed Access
New and future therapies: Changes in the therapeutic armamentarium for SLE
Anca Askanase, Leila Khalili, Wei Tang, et al.
Best Practice & Research Clinical Rheumatology (2023) Vol. 37, Iss. 4, pp. 101865-101865
Closed Access | Times Cited: 9
Anca Askanase, Leila Khalili, Wei Tang, et al.
Best Practice & Research Clinical Rheumatology (2023) Vol. 37, Iss. 4, pp. 101865-101865
Closed Access | Times Cited: 9
Critical Analysis of Cytoplasmic Progression of Inflammatory Signaling Suggests Potential Pharmacologic Targets for Wound Healing and Fibrotic Disorders
Michael L. Samulevich, Liam E. Carman, Brian J. Aneskievich
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2723-2723
Open Access | Times Cited: 2
Michael L. Samulevich, Liam E. Carman, Brian J. Aneskievich
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2723-2723
Open Access | Times Cited: 2
Innovative cell therapies for systemic sclerosis: available evidence and new perspectives
Alain Lescoat, Monalisa Ghosh, Stephan Kadauke, et al.
Expert Review of Clinical Immunology (2024), pp. 1-15
Closed Access | Times Cited: 1
Alain Lescoat, Monalisa Ghosh, Stephan Kadauke, et al.
Expert Review of Clinical Immunology (2024), pp. 1-15
Closed Access | Times Cited: 1
CART Cells and Other Cell Therapies (ie MSC, Tregs) in Autoimmune Diseases
Raffaella Greco, Dominique Farge
Springer eBooks (2024), pp. 837-848
Closed Access
Raffaella Greco, Dominique Farge
Springer eBooks (2024), pp. 837-848
Closed Access
MiR-4769-3p suppresses adipogenesis in systemic sclerosis by negatively regulating the USP18/VDAC2 pathway
Bingsi Tang, Jiangfan Yu, Rui Tang, et al.
iScience (2024) Vol. 27, Iss. 8, pp. 110483-110483
Open Access
Bingsi Tang, Jiangfan Yu, Rui Tang, et al.
iScience (2024) Vol. 27, Iss. 8, pp. 110483-110483
Open Access
Long-term outcome of autologous haematopoietic stem cell transplantation in patients with systemic sclerosis: a comparison with patients treated with rituximab and with traditional immunosuppressive agents
Nicoletta Del Papa, Silvia Cavalli, Andrea Rindone, et al.
Arthritis Research & Therapy (2024) Vol. 26, Iss. 1
Open Access
Nicoletta Del Papa, Silvia Cavalli, Andrea Rindone, et al.
Arthritis Research & Therapy (2024) Vol. 26, Iss. 1
Open Access
Unraveling the Immunometabolism Puzzle: Deciphering Systemic Sclerosis Pathogenesis
Maryam Masoumi, Ali Bodaghi, Hossein Khorramdelazad, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35445-e35445
Open Access
Maryam Masoumi, Ali Bodaghi, Hossein Khorramdelazad, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35445-e35445
Open Access
